The company added a provision to its amended bylaws to allow an individual stockholder or a group of up to 20 stockholders who have owned at least 3 percent of HCA’s common stock for at least three years to nominate directors. Investors who meet those requirements will nominate up to two board seats, according to the SEC filing.
The move comes after activist investor John Chevedden made a proposal earlier this year to allow investors owning at least 10 percent of HCA’s stock to call a special shareholder meeting. His proposal, which gained backing from investors holding only 27 percent of HCA’s stock, was voted down in May, according to the Nashville Post.
More articles on healthcare finance:
Why HCA will fare better than Tenet and CHS under the GOP tax plan
8 health systems with strong finances
Tax bill has major downside for heavily indebted healthcare companies
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.